Ishita Drugs & Indus P/E Ratio

Current P/E Ratio
30.0
High Valuation
Very High - High growth expectations or significantly overvalued

Ishita Drugs & Indus P/E ratio. Ishita Drugs & Indus (ISHITADR) P/E ratio is 30.0 (High), EPS (TTM) ₹2.60, current price ₹78.50 on BSE — Very High - High growth expectations or significantly overvalued. Check ISHITADR market value to track the company's total market size over time.

Current Valuation Metrics

P/E Ratio 30.0
Current Price ₹78.50
EPS (TTM) ₹2.60
Exchange BSE

Valuation Signal

Signal Overvalued

Sector Context

Sector Average 52.28
Sector Median 29.4
Sector Rank #11 of 255
Sector Percentile 4.3%

ISHITADR P/E Ratio — Valuation Signal & Historical Context

Ishita Drugs & Indus P/E 30.0 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see ISHITADR stock price BSE.

  • Stock appears overvalued with PE of 30.0, suggesting caution for new investments
  • Trading at discount to sector average PE of 52.28

ISHITADR vs Healthcare Peers — P/E Ratio Comparison

Ishita Drugs & Indus P/E 30.0 vs Healthcare average 52.28, median 29.4 — range 2.0–733.0.

Sector Average
52.28
Sector Median
29.4
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low